ArticlePloS one2020

HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells.

Martine Auclair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.